Methods |
Women randomly allocated to 2 groups. Method of randomisation not reported |
Participants |
200 women attending in obs/gyn clinic, No. 8 People's Hospital, Wenzhou, Zhejiang, China. Women had regular menstrual periods and a single act of unprotected intercourse within 120 h of attending clinic |
Interventions |
Mife 5 mg vs Mife 10 mg single dose orally |
Outcomes |
Observed number of pregnancies, side effects and changes in menstrual pattern |
Notes |
Observed pregnancy/total number of women: Mife 5 mg 1/100; Mife 10 mg 1/100
-
Side effects:
Mife 5 mg: no side effects recorded
Mife 10 mg: nausea 3/100; breast tenderness 1/100
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Mentioned randomisation but description not adequate |
Allocation concealment (selection bias) |
Unclear risk |
Method of allocation concealment not mentioned |
Blinding (performance bias and detection bias) All outcomes |
Unclear risk |
Not mentioned |
Incomplete outcome data (attrition bias) All outcomes |
Unclear risk |
No mention of post‐randomisation exclusion and loss to follow‐up |
Selective reporting (reporting bias) |
Low risk |
Reported planned outcomes |
Other bias |
Low risk |
None detected |